Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.7B | 2.6B | 2.6B | 2.6B |
Cost of revenue | 2.6B | 2.5B | 2.5B | 2.5B |
Gross profit | 108M | 98M | 115M | 93M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 39M | 31M | 37M | 32M |
Other operating expenses | 2M | 2M | 2M | 2M |
Operating income | 65M | 63M | 74M | 57M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 11M | 10M | 10M | 10M |
Other income expense | -3M | -7M | — | -3M |
Pretax income | 50M | 46M | 64M | 43M |
Tax provision | 12M | 12M | -30M | 11M |
Net income | 38M | 34M | 94M | 32M |
Basic EPS | — | — | 0.4 | 0.1 |
Diluted EPS | — | — | 0.4 | 0.1 |
Basic average shares | — | — | 239.3M | 262.5M |
Diluted average shares | — | — | 243.1M | 265.9M |
EBITDA | 110M | 120M | 119M | 96M |
Net income from continuing op. | 38M | 34M | 94M | 32M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |